Back
Petros Pharmaceuticals 10K Form
Sell
13
PTPI
Petros Pharmaceuticals
Last Price:
0.41
Seasonality Move:
-31.24%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PTPI News And Ratings
See the #1 stock for the next 7 days that we like better than PTPI
PTPI Financial Statistics
Sales & Book Value
Annual Sales: | $5.82M |
---|---|
Cash Flow: | $-1.13M |
Price / Cash Flow: | 0 |
Annual Sales: | $1.42 |
Price / Book: | 0.3 |
Profitability
EPS (TTM): | -7.37000 |
---|---|
Net Income (TTM): | $-8.94M |
Gross Margin: | $4.19M |
Return on Equity: | -76.26% |
Return on Assets: | -27.54% |
Petros Pharmaceuticals Earnings Forecast
Key Petros Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 5 years for PTPI is 71.98%.
- The Selling, General & Administrative Expenses for PTPI have been equal to 159.07% of Gross Profit Margin.
- The Research & Development expenses have been 41.38% of Revenue.
- The Interest Expense is -6.57% of Operating Income.
- The Net Earning history of PTPI is -140.20% of Total Revenues.
- Per Share Earnings over the last 5 years have been positive in 2 years.
Petros Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Pharmaceuticals |
Sector: | Health Care |
Current Symbol: | PTPI |
CUSIP: | 71678J |
Website: | petrospharma.com |
Debt
Debt-to-Equity Ratio: | 0.75 |
---|---|
Current Ratio: | 1.6 |
Quick Ratio: | 1.16 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
PTPI Technical Analysis vs Fundamental Analysis
Sell
13
Petros Pharmaceuticals (PTPI)
is a Sell
Is Petros Pharmaceuticals a Buy or a Sell?
-
Petros Pharmaceuticals stock is rated a Sell
The current Petros Pharmaceuticals [PTPI] share price is $0.43. The Score for PTPI is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.